GQG Partners’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
Other funds holding NVS
GQG Partners's NVS Position: Q3 2026 in Review
GQG Partners reduced its Novartis (NVS) stake by 98% in Q3 2026, selling an estimated $319M and leaving 46,876 shares worth $6.68M. The position accounts for 0.01% of the portfolio, ranked #73.
GQG Partners first reported a position in NVS in Q2 2017 and has held it in 26 quarters since. The position peaked at $435M in Q4 2025. 1,560 funds tracked by Wall St. Rank hold NVS as of Q3 2026.
- GQG Partners held 46,876 shares of Novartis worth $6.68M as of Q3 2026.
- GQG Partners sold 2,104,255 Novartis shares in Q3 2026, an estimated $319M.
- Novartis made up 0.01% of GQG Partners's portfolio in Q3 2026, its #73 holding.
- GQG Partners first reported a position in Novartis in Q2 2017 and has held it in 26 quarters since.
- GQG Partners's Novartis position peaked at $435M in Q4 2025.
- 1,560 funds tracked by Wall St. Rank held Novartis as of Q3 2026.
Based on GQG Partners's 13F filing for Q3 2026, filed 13 Nov 2026.